Home › Hearing Loss › California › Los Angeles
Hearing Loss clinical trials in Los Angeles, CA
5 studies for Hearing Loss are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
RecruitingPhase 1/2
- University of California Los Angeles Medical Center, Los Angeles
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
RecruitingObservational studyHealthy volunteers welcome
- Los Angeles General Medical Center, Los Angeles
- University of Southern California, Los Angeles
Vocal Emotion Communication With Cochlear Implants
RecruitingEarly phase 1Healthy volunteers welcome
- House Institute Foundation, Los Angeles
Benefits of Choir for Older Adults With Unaddressed Hearing Loss (WP2)
Recruiting
- Brain and Creativity Institute, University of Southern California, Los Angeles
Encoding Temporal Fine Structure for Cochlear Implants
RecruitingHealthy volunteers welcome
- University of Southern California, Los Angeles
Hearing Loss trials in other cities
- New York City, NY8 studies
- Washington, DC5 studies
- Baltimore, MD4 studies
- Milwaukee, WI4 studies
- Boston, MA4 studies
- San Francisco, CA3 studies
- Rochester, MN3 studies
- Durham, NC3 studies
- Aurora, CO3 studies
- Cedar Rapids, IA3 studies
- Dallas, TX3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.